APA (7th ed.) Citation

AM, S., & N, F. (2025). Is SBRT the optimal first-line treatment for operable early-stage NSCLC in elderly patients? Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 27(9), 3570. https://doi.org/10.1007/s12094-025-03914-0

Chicago Style (17th ed.) Citation

AM, Soto-Cambres, and Farré N. "Is SBRT the Optimal First-line Treatment for Operable Early-stage NSCLC in Elderly Patients?" Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 27, no. 9 (2025): 3570. https://doi.org/10.1007/s12094-025-03914-0.

MLA (9th ed.) Citation

AM, Soto-Cambres, and Farré N. "Is SBRT the Optimal First-line Treatment for Operable Early-stage NSCLC in Elderly Patients?" Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 27, no. 9, 2025, p. 3570, https://doi.org/10.1007/s12094-025-03914-0.